Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s disease
Chao Gao, Xin Shen, Yuyan Tan, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Roles of Microglia in Neurodegenerative Diseases
Kazuhiro Nakaso
Yonago acta medica (2024) Vol. 67, Iss. 1, pp. 1-8
Open Access | Times Cited: 8
The Vascular-Immune Hypothesis of Alzheimer’s Disease
Rashi I. Mehta, Rupal I. Mehta
Biomedicines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 21
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
Yanaika S. Hok‐A‐Hin, Marta del Campo, Walter Boiten, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Comprehensive review on single-cell RNA sequencing: A new frontier in Alzheimer's disease research
Wengang Jin, Jinjin Pei, Jeane Rebecca Roy, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102454-102454
Closed Access | Times Cited: 4
Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease
Mengting Wang, Ye‐Ran Wang, Gui‐Hua Zeng, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100135-100135
Open Access
Mettl3 regulates the pathogenesis of Alzheimer’s disease via fine-tuning Lingo2
Xingsen Zhao, Chao Ma, Q. Sun, et al.
Molecular Psychiatry (2025)
Closed Access
The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro
Marta Matuszewska, Anna Wilkaniec, Magdalena Cieślik, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 528-528
Open Access
A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis
Stefan Wendt, Ada J. Lin, Sarah N. Ebert, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
Deebika Balu, Ana C. Valencia‐Olvera, Austin Q. Nguyen, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
Joke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review
Mohammad Mahboubi‐Rabbani, Rosa Zarei, Mehdi Baradaran, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 2, pp. 77-95
Closed Access | Times Cited: 8
Integrated transcriptomic and metabolomic profiling reveals dysregulation of purine metabolism during the acute phase of spinal cord injury in rats
Zhong Zeng, Mei Li, Zhan-Feng Jiang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
Untangling Alzheimer’s disease with spatial multi-omics: a brief review
Cody R. Marshall, Melissa A. Farrow, Katerina Djambazova, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 4
Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice
Xueyan Liu, Ping Chen, Wei Wu, et al.
Life Sciences (2024) Vol. 357, pp. 123085-123085
Closed Access | Times Cited: 1
The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer’s disease
Xueyan Liu, Wei Wu, Xuejuan Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 11, pp. 3330-3344
Open Access | Times Cited: 1
HIF-1 signalling pathway was identified as a potential new pathway for Icariin’s treatment against Alzheimer’s disease based on preclinical evidence and bioinformatics
Mingyao You, Ping Yuan, Liangqian Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Unveiling the Impact of Microglial Cells in Alzheimer's Disease Pathogenesis: Insights from Single-Cell RNA-seq Analysis and In Vivo Validation
Nima Sanadgol, Adib Miraki Feriz, Laya Ravanjoo, et al.
Research Square (Research Square) (2024)
Open Access
Gene-Based Management of Alzheimer’s Disease: Role of Coumarins of Ferulago Genus
Farid Dabaghian, Seyede Reyhane Abbasi Husseini Niaraki, Niloufar Azargashb, et al.
(2024), pp. 193-210
Closed Access
To label or not: the need for validation in label-free imaging
Joseph M. Szulczewski, Filiz Yesilköy, Tyler K. Ulland, et al.
Journal of Biomedical Optics (2024) Vol. 29, Iss. S2
Open Access
Multiomics of Aging and Aging-Related Diseases
Olga I. Kiseleva, Viktoriia A. Arzumanian, Yuri A. Ikhalaynen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13671-13671
Open Access
Potential natural product 3,4-seco-schitriterpenoids from Kadsura japonica L. as anti-neuroinflammatory agents
Shu‐Hsiang Liu, Hung‐Tse Huang, I‐Wen Lo, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106843-106843
Closed Access | Times Cited: 1
Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one Downregulation of Galectin‐3 Alleviates Amyloid beta-induced Neuroinflammation and Cognitive Impairment in a mouse Alzheimer's disease model
Xueyan Liu, Ping Chen, Wei Wu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top